{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:02:54Z","timestamp":1781186574836,"version":"3.54.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1053\/j.seminoncol.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T07:32:06Z","timestamp":1679383926000},"page":"25-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships"],"prefix":"10.1053","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5708-276X","authenticated-orcid":false,"given":"Rabbia","family":"Tariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtebaat","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad H.","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiuddin","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizan","family":"Niaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed M.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.seminoncol.2023.03.002_bib0001","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1182\/blood-2011-08-358135","article-title":"Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience","volume":"119","author":"Kantarjian","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0002","first-page":"CMBD","article-title":"Clinical and hematological features of 335 patients of chronic myelogenous leukemia diagnosed at single centre in northern Pakistan","volume":"5","author":"Bhatti","year":"2012","journal-title":"Clin Med. Blood Dis"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0003","unstructured":"World Chronic Myeloid Leukemia Day: Leukemia common among younger Pakistanis. Express Tribune Web Archives 26 September 2013:5. Available at: https:\/\/tribune.com.pk\/story\/609805\/world-chronic-myeloid-leukemia-day-leukemia-common-among-younger-pakistanis. Accessed June 29, 2022."},{"issue":"11","key":"10.1053\/j.seminoncol.2023.03.002_bib0004","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.clinthera.2015.08.026","article-title":"Response and adverse effects of nilotinib in imatinib-resistant chronic myeloid leukemia patients: data from a developing country","volume":"37","author":"Hussain","year":"2015","journal-title":"Clinical therapeutics"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0005","unstructured":"Yusufzai Mushtaq. KP govt to continue providing free treatment to poor cancer patients. The News International. 23 September 2019. Available at: https:\/\/www.thenews.com.pk\/print\/530827-kp-govt-to-continue-providing-free-treatment-to-poor-cancer-patients. Accessed July 3, 2022."},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0006","series-title":"Conference Proceedings for the International Forum on Quality Cancer Care September 8 and 9, 2018","first-page":"49","volume":"1","year":"2018"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0007","unstructured":"Chaudhry Asif. Lahore\u2019s cancer patients protest disruption of medicine supply. Dawn News. 12 May 2022. Available at: https:\/\/www.dawn.com\/news\/1689162. Accessed July 7, 2022."},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0008","unstructured":"K-P CM approves free treatment for cancer patients. Express Tribune Web Archives 7 April 2019:7. Available at: https:\/\/tribune.com.pk\/story\/1945052\/k-p-cm-approves-free-treatment-cancer-patients. Accessed July 8, 2022."},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0009","article-title":"Challenges in access to new therapeutic agents: marginalized patients with cancer in pakistan and the need for new guidelines","volume":"8","author":"Aziz","year":"2022","journal-title":"JCO Global Oncol"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0010","first-page":"12","article-title":"Cancer prevention and control in the context of an integrated approach","year":"2017","journal-title":"World Health Assembl Resol"},{"issue":"2","key":"10.1053\/j.seminoncol.2023.03.002_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JGO.2015.000398","article-title":"International framework for cancer patient advocacy: empowering organizations and patients to create a national call to action on cancer","volume":"1","author":"Schear","year":"2015","journal-title":"J Global Oncol"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0012","unstructured":"Ousat Ali. Sindh Govt\u2019s reluctance puts life of blood cancer patients in jeopardy. Bol News 14 Sep 2021. https:\/\/bolnews.com\/latest\/2021\/09\/sindh-govts-reluctance-puts-life-of-blood-cancer-patients-in-jeopardy. Accessed July 09, 2022."},{"issue":"6","key":"10.1053\/j.seminoncol.2023.03.002_bib0013","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nrclinonc.2013.55","article-title":"Access to cancer medications in low-and middle-income countries","volume":"10","author":"Lopes","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0014","unstructured":"WHO. Trade-related aspects of intellectual property rights. http:\/\/www.wto.org\/english\/tratop_e\/trips_e\/trips_e.htm (2013). Accessed July 12, 2022."},{"issue":"1","key":"10.1053\/j.seminoncol.2023.03.002_bib0015","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jval.2011.11.016","article-title":"Impact of the introduction of government use licenses on the drug expenditure on seven medicines in Thailand","volume":"15","author":"Mohara","year":"2012","journal-title":"Value Health"},{"key":"10.1053\/j.seminoncol.2023.03.002_bib0016","unstructured":"A health check for a better future: unleashing the potential of pharmaceuticals in Pakistan. https:\/\/cdpr.org.pk\/wp-content\/uploads\/2021\/06\/Unleashing-the-Potential-of-Pharmaceuticals-in-Pakistan.pdf. Accessed July 13, 2022."}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775423000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775423000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:57:15Z","timestamp":1758805035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775423000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":16,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0093775423000374"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2023.03.002","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Battling chronic myeloid leukemia in a resource-constrained country: A case of public-private partnerships","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}